Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.7200 (-5.45%) ($7.7200 - $7.7200) on Fri. Mar. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.45% (three month average) | RSI | 25 | Latest Price | $7.7200(-5.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3% a day on average for past five trading days. | Weekly Trend | EDIT declines -6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(68%) IBB(55%) IWC(49%) IWM(45%) IWO(45%) | Factors Impacting EDIT price | EDIT will decline at least -2.225% in a week (0% probabilities). IGOV(-14%) VIXM(-12%) SMH(-12%) BNDX(-6%) UUP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.225% (StdDev 4.45%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.4(-169.95%) | Resistance Level | $9.15 | 5 Day Moving Average | $8.37(-7.77%) | 10 Day Moving Average | $8.62(-10.44%) | 20 Day Moving Average | $9.15(-15.63%) | To recent high | -32.4% | To recent low | 0% | Market Cap | $479m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |